SEVGI (𝓞𝓻𝓲𝓰𝓲𝓷𝓪𝓵) 🕊
Sevgi haqida eng chiroyli stroieslar 💜 ▪️Creator: @Sevgilllove
Show more📈 Analytical overview of Telegram channel SEVGI (𝓞𝓻𝓲𝓰𝓲𝓷𝓪𝓵) 🕊
Channel SEVGI (𝓞𝓻𝓲𝓰𝓲𝓷𝓪𝓵) 🕊 (@sevgi) in the Uzbek language segment is an active participant. Currently, the community unites 22 732 subscribers, ranking 1 122 in the Motivation & Quotes category and 3 522 in the Uzbekistan region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 22 732 subscribers.
According to the latest data from 10 June, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -551 over the last 30 days and by -36 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 39.33%. Within the first 24 hours after publication, content typically collects 14.59% reactions from the total number of subscribers.
- Post reach: On average, each post receives 8 942 views. Within the first day, a publication typically gains 3 317 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 29.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“Sevgi haqida eng chiroyli stroieslar 💜
▪️Creator: @Sevgilllove”
Thanks to the high frequency of updates (latest data received on 11 June, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Motivation & Quotes category.
Қачонгача шунақа семиз булиб юрмоқчисиз? балки узгариш вақти келгандир, хар бир кг ортиқча вазн бу касаллик.НИМА ВОСИТА ЭКАНИНИ МАНА БУ ЕРДАН БИЛИБ ОЛИНГ 👇👇👇👇👇👇👇👇👇 https://dexpress-uz.shop/f9/7 https://dexpress-uz.shop/f9/7 Қўллаб кўрганлар натижасидан мамнун. Сиз ҳам синаб кўринг❗️
Available now! Telegram Research 2025 — the year's key insights 
